報價延遲最少15分鐘:2025/01/21 08:47 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.29/-0.45
|
|
企業價值
58.76M
|
| 資產負債 |
|
每股賬面淨值
2.70
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
422.11K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:47 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). |